Intermediate-size Expanded Access to ONC201 for Patients with H3 K27M-mutant and/or Midline Gliomas
Categories (click each to see list of all clinical trials associated with that category): Brain/Neuro (ONC)
Current Status: Open
Phase: N/A (Cancer Control)
Principal Investigator: Shonka, Nicole
Contact Information:
Michaela Savine
misavine@unmc.edu
Eligibility: https://www.clinicaltrials.gov/study/NCT04617002?term=NCT04617002&rank=1
Summary
To provide expanded access to ONC201 for patients with H3 K27M-mutant and/or midline gliomas who cannot access ONC201 through clinical trials.